Abstract | Innate lymphocytes -including natural killer cells and the recently discovered innate lymphoid cells -have crucial roles during infection, tissue injury and inflammation. Innate signals regulate the activation and homeostasis of innate lymphocytes. The contribution of the adaptive immune system to the coordination of innate lymphocyte responses is less well understood. In this Opinion article, we review our current understanding of the interactions between adaptive and innate lymphocytes, and propose a model in which T cells of the adaptive immune system function as antigen-specific sensors for the activation of innate lymphocytes to amplify and instruct local immune responses. We highlight the potential roles of regulatory and helper T cells in these processes, and discuss major questions in the emerging area of crosstalk between adaptive and innate lymphocytes.
Different types of immune cells cooperate to achieve a finely balanced state of the immune system that maintains tolerance to self antigens, beneficial microsymbionts and nutrients, but enables the elimination or neutralization of pathogens, tumours, allergens and xenobiotics. It is now appreciated that innate lymphocytes -including natural killer cells (NK cells) and the recently discovered innate lymphoid cells (ILCs) -are strategically positioned in many tissues of the body to exert crucial functions during infection, tissue injury and inflammation. These functions include direct cyto toxicity, the secretion of tissue-protective factors and the production of cytokines that help to coordinate protective immune responses (for reviews, see (FIG. 1) .
NK cells and ILCs may have evolved to provide a rapid response to environmental challenges. Myeloid and epithelial cell-derived cytokines and alarminssuch as interleukin-12 (IL-12), IL-23 and IL-33 -can directly activate these innate lympho cytes without requiring their further differentiation (BOX 1) . The ease by which these cells can be activated has to be balanced by stringent control mechanisms, because excessive activation may contribute to a loss or impairment of tissue function and facilitate inflammatory processes. Indeed, innate lymphocytes have recently been implicated in inflammatory disorders including diabetes, allergic asthma, atopic dermatitis, inflammatory bowel diseases, organ fibrosis and cancer [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Insufficient function of innate lymphocytes can lead to tissue dysfunction, barrier breach and severe pathology during local infection 15, 16 . The mechanisms that regulate the activation of innate lymphocytes are therefore highly relevant for a broad range of physiological and pathological immune responses.
Current research has largely focused on the role of innate cytokines that are produced by myeloid, epithelial and stromal cells in regulating the homeostasis and function of innate lymphocytes [1] [2] [3] Although it has been less well studied so far, the adaptive immune system may also contribute to the activation of innate lymphocytes and the regulation of their responses. One hallmark of allergic and autoinflammatory diseases, as well as of recurrent or persisting infections, is the sensitization of adaptive T cells to allergens and tissue-derived or pathogen-derived antigens, respectively. Upon re-exposure to their cognate antigen, these T cells initiate immunity to a large extent by further recruiting innate effector cells of the myeloid lineages and coordinating their responses (as reviewed in REF. 17 ). ILCs and NK cells have recently been found to participate in shaping and regulating adaptive immune responses [18] [19] [20] [21] , but little is known about how adaptive immunity instructs innate lymphocytes. In this Opinion article, we review our current understanding of the interactions between adaptive and innate lymphocytes. We focus on NK cells and ILCs, and do not discuss 'innate-like' T cells (such as γδ T cells and NK or NK-like 'innate' CD8 + T cells) or the interactions between innate lymphocytes and B cells, although some of the principles that are discussed here may also apply for these cells 22, 23 . We propose a model in which adaptive T cells function as peripheral antigen-specific sensors that recruit and activate innate lymphocytes to amplify and coordinate local immune responses. We focus on the potential role of forkhead box P3 (FOXP3)-expressing regulatory T (T Reg ) cells and CD4 + T helper (T H ) cells in these processes. Finally, we highlight major questions and challenges in the emerging area of crosstalk between adaptive and innate lymphocytes.
Innate lymphocytes in adaptive immunity
Innate lymphocytes could directly or indirectly influence adaptive immune responses through cell contact-dependent inter actions and soluble mediators, or by having effects on accessory cells including antigenpresenting cells (APCs) and stromal cells. One can envision that NK cells and ILCswhich have also been dubbed 'innate helper cells' -could coordinate and polarize major types of the adaptive immune response owing to their ability to produce classical T H cell cytokines (FIG. 1) . These cytokines are known to modulate the number and activity of myeloid cells -including neutrophils, eosinophils, macrophages and dendritic cells (DCs) -but they can also act directly on T cells. Local conditioning of the cytokine milieu by NK cells and ILCs may, therefore, directly and/or indirectly contribute to the initiation and polarization of the adaptive immune response (FIG. 2b) .
The role of NK cells is the best studied in this regard. The early production of interferon-γ (IFNγ) by NK cells can modulate APC function and promote the differentiation of T H 1 cells directly, and also indirectly by inhibiting the differentiation of T H 2 and T H 17 cells (for a review, see REF. 24 ). The 'ILC1-like' NK cells (BOX 2) that are present in secondary lymphoid organs and produce increased amounts of IFNγ might be particularly well suited for this purpose [25] [26] [27] [28] . Similarly, ILC2-derived IL-4 and IL-13 may reinforce the priming of T H 2 cells and potentially inhibit T H 1 cell polarization. Consistent with this idea, ILC2-derived IL-13 was recently shown to be crucial for the initiation of T H 2 cell-mediated allergic responses 12 . ILC2s can also directly stimulate T H 2 cell responses in vitro 29 and facilitate antigen-specific T cell responses during helminth infection 30 . A similar function for ILC3s in promoting T H 17 cell responses through cytokine production is conceivable, because the early innate production of IL-17 (for example, by γδ T cells) can function as a feedforward mechanism to increase further T H 17 cell differentiation 31, 32 . ILC3s are also a source of granulocyte-macrophage colonystimulating factor (GM-CSF; also known as CSF2), which can support T Reg cell homeostasis and generation in the gut 33 . Furthermore, the functions of ILCs in lymphoid tissue organogenesis might also be relevant for 36 . Interestingly, TRAIL is also expressed by mouse hepatic and splenic ILC1-like NK cells that accumulate during chronic LCMV infection 37 , which raises the possibility that these NK cells might have regulatory roles during infection.
The idea that innate lymphocytes may be involved in the regulation and tuning of T cell responses in specific environments is further supported by the intriguing observation that retinoic acid receptor-related orphan receptor-γt (RORγt)-expressing ILC3s can process antigens and present them on MHC class II molecules 18 . Mice in which ILC3s lacked MHC class II expression developed CD4 + T cell-dependent intestinal inflammation that was abrogated by antibiotic treatment 18 . Hence, ILCs might limit pathology that is induced by adaptive immune responses to the commensal microbiota at mucosal sites.
Adaptive control of innate lymphocytes
Recent studies suggesting a role for ILCs in the instruction and regulation of adaptive immunity 12, 18, 20 are intriguing, as they go beyond the frequent use of lymphopenic mice to study ILCs and they provide experimental evidence for physiological functions of [41] [42] [43] [44] , and also during auto immune challenge 8, 14 , transplant rejection 45 and infection [46] [47] [48] . Mechanistically, it has been proposed that T Reg cells suppress NK group 2 member D (NKG2D)-mediated NK cell cytotoxicity through transforming growth factor-β (TGFβ), potentially involving a contactdependent mechanism 41, 42 . T cell help for NK cells was mediated either indirectly by IL-15-trans-presenting DCs T cell-derived IL-2 facilitates the proliferative expansion of NK cells during infection 46 , and the production of IL-2 by antigen-specific T cells activates human NK cells in blood samples from vaccinated individuals 52, 53 . The innate cytokines IL-12 and IL-18 induce the expression of the high-affinity IL-2 receptor subunit CD25 (also known as IL-2Rα) on NK cells, which may enable these cells to compete for IL-2 in vivo 37, 43, 48 . Furthermore, CD25-deficient LY49H + NK cells expand significantly less than their wild-type counterparts during murine cytomegalovirus (MCMV) infection (G.G. and A.Y.R., unpublished observations). T Reg cells limit the availability of IL-2 by restraining the activation of effector T cells. Furthermore, T Reg cells -which constitutively express high levels of CD25 -may actively deplete IL-2 from the local environment through the 'consumption' of the cytokine 54 . In addition to its function in promoting NK cell proliferation, IL-2 was shown to increase NK cell cytotoxicity through translation-dependent mechanisms 51, 55 . Adding to the pleiotropic effects of IL-2, we recently found an unexpected immediate role for this cytokine in lowering the activation threshold of NK cells by increasing their ability to adhere to and engage their target cells 56 . By restraining the availability of IL-2, T Reg cells seem to increase the activation threshold of NK cells, a mechanism that might be of particular relevance to the restraint of NK cell-mediated tissue damage in inflamed tissues that contain highly activated T cells. Consistent with this idea, excessive amounts of IL-2 rapidly activated NK cells and exacerbated diabetes in T Reg celldepleted pre-diabetic mice 8 . Autoimmunity 73 (FIG. 2) , a major question is whether ILCs also integrate environmental cues through activating and inhibitory receptors. By analogy to established models of 'missing-self', 'altered-self' and 'non-self' recognition by NK cells 81 , ILCs may express receptors that recognize epithelial or microbial ligands, and signalling through these receptors may be crucial for tolerance and ILC function at mucosal sites. Interactions between different innate lymphocyte subsets currently remain largely unexplored.
that is facilitated by the unrestrained activation of NK cells may therefore be triggered when the IL-2-buffering capacity of T Reg cells is compromised or exceeded 57 . Of therapeutic benefit, NK cell cytotoxicity may be rapidly increased by strategies that enable NK cells to compete for IL-2 by increasing CD25 expression 43 or by the targeted delivery of IL-2 (REFS 8,43).
ILC1-like NK cells.
The factors defining the heterogeneity, and the specific functions and cellular interactions, of particular subsets of ILCs are currently being investigated. Recent studies indicate that the expression of eomesodermin (EOMES) distinguishes cNK cells from ILC1-like NK cells 58, 59 
Interestingly, adaptive immune responses that are associated with chronic inflammation can drive the expansion of a phenotypically related, IL-2-responsive NK cell subset that expresses CD127 (also known as IL-7Rα) 37 . These ILC1-like NK cells accumulated in the spleens of T Reg cell-depleted mice, as well as in tumour-bearing and chronically infected mice 37 . 
Consumption
Cytokine production DC or monocyte phenotype, and by high levels of IFNγ production, yet they lack potent cytotoxic activity 25, 26 . Human CD56 hi NK cells can also express CD25, and low-dose IL-2 treatment of patients with cancer or healthy volunteers preferentially expanded this cell subset 60, 61 . The observed similarities between mouse ILC1-like NK cells and human CD56
hi NK cells raise the possibility that the latter might also proliferate in response to IL-2-induced CD25 signalling. Interestingly, human CD56
hi NK cells -in parallel with their potential mouse counterparts -are present in increased numbers at sites of chronic inflammation in patients with tuberculosis, sarcoidosis, rheumatoid arthritis and cancer [62] [63] [64] . These observations highlight the need for future studies to investigate the heterogeneity, physiological functions and cellular interactions of ILC1s and ILC1-like cells in specific contexts, including secondary lymphoid organs, the thymus, the liver, mucosal barrier sites, tumours and settings of chronic inflammation 28, 37, 58, 65, 66 .
ILC2s. The role of T cells in regulating the function of bona fide ILCs is currently less well understood. Interestingly, however, several recent studies indicate that IL-2 may also be important for the regulation of ILC2s. ILC2s have been found in the dermis, lungs, liver, visceral adipose tissue and gut, and they typically express high levels of CD25 (REFS 6, 7, 13, 16) . The activation of ILC2s with IL-33 increases CD25 expression 7 , and IL-2 has been used to activate and to expand ILC2 populations in vitro and in vivo 16, 67, 68 . ILC2s express receptors for the signal transducer and activator of transcription 5 (STAT5)-activating cytokines IL-2, IL-7 and thymic stromal lymphopoietin (TSLP), as well as the nuclear factor-κB (NF-κB)-activating cytokines IL-25 and IL-33 (REF. 67 ). IL-25 or IL-33 alone can activate ILC2s to produce IL-5 and/or IL-13, but the presence of a STAT5-activating cytokine further increases cytokine production by ILC2s in vitro 67 . Accordingly, IL-2 has been shown to facilitate IL-9 production by pulmonary ILC2s in a model of papain-induced airway hyperreactivity 13 . The prolonged treatment of Rag2 −/− mice (which lack the gene encoding recombination activating protein 2) with IL-2 resulted in the proliferative expansion and activation of dermal ILC2s, and the induction of allergic skin disease 6 . In addition to a role for IL-2 in co-activating ILC2s, IL-2 might also modulate the homeostasis, proliferation and survival of ILC2s. Despite these important findings, it is currently unclear to what extent ILC2s access the IL-2 that is produced under physiological conditions. Our recent studies indicate that CD25 expression confers a competitive advantage to 
◀

Major questions
In summary, a growing number of studies support the concept that a tricellular crosstalk between T H cells, T Reg cells and innate lymphocytes may be involved in the regulation and function of innate effector lymphocytes, and that IL-2 is one important mediator of this adaptive-innate crosstalk. This concept raises several important, and as yet unanswered, questions including how the IL-2-dependent crosstalk occurs at the cellular, molecular and spatiotemporal levels, and which IL-2-independent mechanisms can potentially mediate the adaptive control of innate lymphocytes.
The source and the sensing of IL-2.
Although T cells are clearly a predominant source of IL-2 in the immune system, other cell types have also been proposed to secrete IL-2. In particular, cNK cells, EOMES − hepatic NK cells and ILC2s can produce IL-2 when stimulated under certain conditions 16, 58 . IL-2 secretion by innate lymphocytes has been proposed 16, 58, 66 , but its potential physiological relevance is currently unclear. For example, it is unclear whether IL-2 secreted by innate lymphocytes might function in an autocrine manner or in a paracrine manner, as a potential early source of IL-2 for effector T cell activation or T Reg cell homeostasis.
It has been estimated that only cells in very close proximity would be able to 'help' or 'regulate' each other through the paracrine provision or competitive deprivation of IL-2, respectively 70, 71 . Therefore, a major question is whether T cells and innate lymphocyte subsets interact in a spatiotemporal manner that would enable direct IL-2-dependent help and regulation. Intriguingly, only IL-2-producing CD4 + T cells could 'help' the NK cell response during experimental Leishmania major infection, but unambiguous evidence for a direct paracrine effect is lacking 46, 72 . Attempts to discriminate the direct, cellintrinsic effects of IL-2 from indirect effects that are mediated by additional cell types are complicated by the lack of studies using conditional alleles of the genes encoding IL-2 and CD25, as well as by the shared use of common receptor subunits by different cytokines -for example, CD122 (also known as IL-2Rβ) binds IL-2 and IL-15, and CD132 (also known as the common γ-chain) signals in response to IL-2, IL-4, IL-7, IL-9 and IL-15. Nevertheless, a role for cell-intrinsic IL-2-induced CD25 signalling in vivo was demonstrated for splenic ILC1-like NK cells 37 and has been observed for cNK cells during MCMV infection, as well as for ILC2s during homeostasis (G.G. and A.Y.R, unpublished observations). In summary, although several studies suggest that IL-2 is a crucial cytokine for the regulation of innate lymphocytes, and that T H cells and T Reg cells might regulate innate lymphocyte activation and proliferation by modulating the availability of IL-2, a formal demonstration of the relevant cell ular sources of IL-2 and the immediate sensors, as well as where and when these interactions take place, is currently lacking. Addressing these questions will help us to better understand the IL-2-dependent adaptive-innate lymphocyte crosstalk.
IL-2-independent mechanisms. ILC3s do not generally express the high-affinity IL-2 receptor subunit CD25, and cNK cells require innate triggers to induce the upregulation of CD25. As discussed above, T Reg cells can also suppress cNK cells in a contact-dependent manner or through the control of DC function 41, 42, 49 . Furthermore, subsets of NK cells, ILC2s and ILC3s have been reported to express MHC class II molecules and may directly interact with CD4 + T cells 18, [86] [87] [88] . These observations argue for the existence of additional IL-2-independent pathways by which T cells can either recruit and activate, or inhibit, innate lymphocytes. Potential mechanisms include the secretion of other cytokines and chemokines, direct contactdependent interactions, and mechanisms involving accessory cells (DCs or macrophages) that mediate the activation or inhibition of innate lymphocytes 73 (FIG. 2c) .
In addition, T cells and innate lymphocytes could potentially regulate each other through competition for cytokines (such as IL-2 and IL-7, and potentially IL-12, IL-18 and IL-33), nutrients or access to DCs and macrophages. Such competition for resources is a well-established principle for T cells and may also be relevant in the context of T cell-innate lymphocyte interactions. Future studies are needed to define the additional pathways that mediate adaptive-innate lymphocyte crosstalk at mucosal sites. These studies would benefit from the development of mouse models in which genetic manipulation is restricted to innate lymphocytes.
Coupling adaptive and innate responses
As discussed above, a growing body of evidence indicates that reciprocal interactions between innate and adaptive lympho cytes are likely to be important for immune responses at the sites at which innate lympho cytes typically reside. Effector T cells enter these tissues during acute injury or infection-induced inflammation
Box 2 | NK cells and ILC1s
Group 1 innate lymphoid cells (ILCs) are a heterogeneous group of cells that includes natural killer (NK) cells and ILC1s. The developmental relationship between individual group 1 ILC subsets, and their distinguishing phenotypic features and functions, are currently being defined. In C57BL/6 mice, NK cells typically express NK1.1 (also known as KLRB1C), a marker that is also found on ILC1s and some ILC3s, as well as CD4 + NKT cells and subsets of CD8 + T cells. Recent studies suggest that the expression of eomesodermin (EOMES) distinguishes conventional NK (cNK) cells from cells that were originally described as phenotypically immature 82 , but that are now thought to represent an independent cell lineage 58, 83 . Although they have been best characterized in the liver, lineage-negative (LIN − ) EOMES − NK1.1 + cells have also been identified in the thymus, lymph nodes, spleen, bone marrow, skin, lungs and gut 59, 66 . When compared with EOMES + cNK cells, these EOMES − cells are highly responsive to interleukin-12 (IL-12), produce increased amounts of cytokines and are characterized by high levels of expression of CD90 (also known as THY1), CD127 (also known as IL-7Rα), CD69 and CXC-chemokine receptor 3 (CXCR3), and a paucity of expression of LY49 NK cell receptors; this surface phenotype is reminiscent of ILC1s 5, 59 . Recent studies indicate that ILC1s and hepatic EOMES − NK cells develop from a common precursor that is distinct from the cNK cell precursor 58, 59, 84 . 58, 65, 66 . Future studies are needed to fully elucidate the differentiation, physiological functions and interactions of these cells in their specific tissue environments.
and although the majority of effector T cells disappear from the tissue upon resolution of inflammation, some differentiate into peripheral tissue-resident memory T cells. These cells have important functions in the early defence against reinfection 74, 75 . Although it is not clear to what extent the capacity to accommodate memory T cells in non-inflamed peripheral niches is limited [76] [77] [78] , it is probable that under homeostatic conditions, only a few T cells with a given specificity are present at major pathogen entry sites such as the skin, lungs, genital tract or gut. A major question is, therefore, how a limited number of memory T cells can confer initial protection against invasion by pathogens that replicate and spread rapidly before large numbers of antigen-specific T cells can be expanded and recruited from the lymph nodes.
We propose that T cells, in addition to their direct effector function, amplify their response by functioning as antigen-specific sensors that activate and instruct tissueresident innate lymphocytes to provide local protection against tissue damage and pathogen invasion. T cells are known to coordinate the responses of other immune cells. For example, T cells facilitate the recruitment and activation of leukocytes (including neutrophils, eosinophils, macrophages and monocytes) or additional T cells through cytokines and chemokines 17, 79 . Memory T cells -particularly tissue-resident memory T cells -are activated early during acute injury and infections 74, 75 , and they increase and accelerate innate immune cell recruitment and activation 39, 79 . This "sensing and alarm function" (REF. 79 ) of memory T cells might extend to the activation of tissueresident innate lymphocytes. Thus, we suggest that upon antigen recognition, tissueresident T cells modulate the responsiveness of innate lymphocytes, together with the cues provided by activating and inhibitory receptors, and by innate cytokines (FIG. 3) . In support of this idea, some of the innate cytokines that activate both innate lymphocytes and T cells (such as IL-12, IL-18 and IL-33) also upregulate the expression of the high-affinity IL-2 receptor subunit CD25 on cNK cells, ILC1-like NK cells and ILC2s 7, 37, 48 . Increased CD25 expression renders the innate lymphocytes more responsive to IL-2 -a prototypic T cell cytokine that is released early after T cell receptor stimulation and co-activates these cells 6, 8, 13, 46, 56, 72 which drives their proliferation 6, 37, 43, 46, 48 . The evidence that innate cytokines prepare ILCs to receive a T cell-derived activating signal provides the basis for a two-step model of the crosstalk between T cells and innate lymphocytes. Additional T cell-derived cytokines (such as IFNγ, IL-4, IL-5, IL-13 and IL-17) may also act on innate lymphocytes either directly or indirectly by activating tissue-resident macrophages and DCs. In support of this concept, IFNγ secreted by memory T cells during recall infection accelerated and potentiated the activation of innate cells, including monocytes, macrophages and NK cells 39 . The rapid T cell-dependent 'innate recall' of NK cells required IFNγ signalling in monocytes and macrophages, and was associated with accelerated IL-12 production. Intriguingly, these observations suggest that the activation of memory T cells can, in fact, precede the full activation of the studied innate cells (REF. 39 ).
The T cell-mediated activation of innate lymphocytes could amplify the corresponding protective antigen-specific response type and also reinforce the beneficial, specialized functions of innate lymphocytes (FIG. 3 ).
An example of such specialized functions could be the production of tissue-protective factors by ILCs to prevent inflammationinduced impairment of organ function, and to prevent pathogen invasion and secondary infections. Furthermore, we suggest that IL-2-induced enhancement of NK cell cytotoxicity probably makes NK cells more efficacious at preventing immune evasion by pathogens or tumours that induce MHC class I downregulation 56 .
In addition to the amplification of ILC responses and numbers, antigen-dependent modulation by T cells would also link the full activation of innate lymphocytes to the elaborate mechanisms of tolerance and regulation of T cell responses. The latter would include the control of innate lymphocytes by T Reg cells. In this regard, T Reg cells could limit the 'access' of innate lymphocytes to IL-2 by inhibiting IL-2 production by T cells, depriving the environ ment of IL-2 through consumption and inhibiting the expression of CD25 by ILCs. Inhibiting CD25 expression could potentially be achieved by multiple means including inhibiting the production of the CD25-inducing cytokines IL-12 and IL-18 by macrophages and DCs; competing for IL-12, IL-18 and IL-33; or producing inhibitory cytokines (such as TGFβ) that might prevent the upregulation of CD25 (REF. 37 ). Therefore, one function of T Reg cells might be to restrain the T cell 'help' that innate lymphocytes receive, so as to prevent the excessive activation of these cells and the subsequent impairment in tissue function (FIG. 3) .
Notably IL-2 consumption and T Reg cell activation
